Moonlake Immunotherapeutics Stock Performance
as on October 22, 2025 at 1:29 am IST
Day's Low
Day's High
$9$9.35
1.75%
Downside
2.07%
Upside
52 Week's Low
52 Week's High
$5.95$62.7535.04%
Downside
585.04%
Upside
Moonlake Immunotherapeutics share price movements today
- Previous Close
- $9.36
- Open
- $9.35
- Volume
- 2.3M
- Day's Low - High
- $9 - $9.35
- 52 Week Low - High
- $5.95 - $62.75
Moonlake Immunotherapeutics Historical Returns
- 1 Month Return
- -82.61 %
- 3 Month Return
- -82.54 %
- 1 Year Return
- -80.92 %
- 3 Year Return
- + 10.71 %
- 5 Year Return
- 0 %
Moonlake Immunotherapeutics Stock Fundamentals & Key Indicators
Check Moonlake Immunotherapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$579.1M
EPS (TTM)
-3.332
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
0EBITDA
-199.0M
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
8206700.00%
Moonlake Immunotherapeutics vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Moonlake Immunotherapeutics with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $579.1M | NA | NA | 0.00% | |
| BUY | $35.5B | 359.02% | -16.34 | -259.82% | |
| BUY | $63.1B | 259.92% | -505.15 | -12.96% | |
| BUY | $106.9B | 98.27% | 29.67 | 31.86% | |
| BUY | $61.3B | 0.76% | 14.58 | 31.37% |
Stock Returns calculator for Moonlake Immunotherapeutics Stock including INR - Dollar returns
The Moonlake Immunotherapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Moonlake Immunotherapeutics investment value today
Current value as on today
₹23,494
Returns
Returns from Moonlake Immunotherapeutics Stock
Dollar Returns*
₹4,808 (+4.81%)
Analyst Recommendation on Moonlake Immunotherapeutics Stock
Based on 22 analysts
81.82%
Buy
18.18%
Hold
0.00%
Sell
Based on 22 analysts, 81.82% of analysts recommend a 'BUY' rating for Moonlake Immunotherapeutics. Average target price of $13.08
Moonlake Immunotherapeutics Share Price Target
Get share price movements and forecasts by analysts on Moonlake Immunotherapeutics.
What analysts predicted
29.97%UPSIDE
Target Price
$13.08
Current Price
$9.16
Analyzed by
22 Analysts
Target
$13.08
Moonlake Immunotherapeutics target price $13.08, a slight upside of 29.97% compared to current price of $9.16. According to 22 analysts rating.
Moonlake Immunotherapeutics Stock’s Investor Sentiment and Interest
Investment in Moonlake Immunotherapeutics Shares on INDmoney has grown by 11622.22% over the past 30 days, indicating increased transactional activity.
Time period: to
Change:11622.22% versus previous 30 day period
Search interest for Moonlake Immunotherapeutics Stock has increased by 6438% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:6438% versus previous 30 day period
Moonlake Immunotherapeutics Quarterly Profit & Loss
All numbers in Millions USD
Moonlake Immunotherapeutics Annual Profit & Loss
All numbers in Millions USD
Moonlake Immunotherapeutics Quarterly Cash Flow
All numbers in Millions USD
Moonlake Immunotherapeutics Annual Cash Flow
All numbers in Millions USD
Moonlake Immunotherapeutics News & Key Events
Today's Timeline - 29 September
Mon, 07:03 PM
-MoonLake stock down 90% after disappointing Phase 3 VELA trial results, triggering heavy trading activity.
Mon, 07:18 PM
-Analyst downgrades MoonLake to Hold, citing unfavorable Phase 3 results and uncertain market prospects.
Tue, 07:19 AM
-MoonLake stock plummets 89.93% despite significant trial results; after-hours trading shows slight recovery.
Insights on Moonlake Immunotherapeutics
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
NO EFFECTAgainst Peers
In the last 3 years, Insmed Incorporated has given 809.6% return, outperforming this stock by 798.9%
- NO EFFECT
Against Peers
In the last 1 year, Insmed Incorporated has given 132.3% return, outperforming this stock by 213.2%
NEGATIVE IMPACTPrice Dip
In the last 1 month, MLTX stock has moved down by -82.6%
About Moonlake Immunotherapeutics
| Organisation | Moonlake Immunotherapeutics |
| Headquarters | Dorfstrasse 29, Zug, Switzerland, 6300 |
| CEO | Dr. Jorge Santos da Silva Ph.D. |
| E-voting on shares | Click here to vote |
Key Management of Moonlake Immunotherapeutics
Name | Title |
|---|---|
Dr. Jorge Santos da Silva Ph.D. | Co-Founder, CEO & Director |
Dr. Kristian Reich M.D., Ph.D. | Co-Founder & Chief Scientific Officer |
Luciana Marques | Director of HR, People & Culture |
Mr. Nicolas Mosimann Ph.D. | General Counsel |
Joana Cortez | Senior Director Legal & Compliance |
Tino Anthamatten | Vice President of Marketing, Market Access & Pricing |
Ms. Nuala Brennan | Chief Clinical Development Officer |
Mr. Matthias Bodenstedt | Chief Financial Officer |
Mr. Oliver Daltrop Ph.D. | Chief Operations Officer |
Ms. Carla Bretes | Director of Investor Relations & External Communications |
FAQs
What is Moonlake Immunotherapeutics share price today?
Moonlake Immunotherapeutics share price today is $9.16 as on at the close of the market. Moonlake Immunotherapeutics share today touched a day high of $9.35 and a low of $9.
What is the 52 week high and 52 week low for Moonlake Immunotherapeutics share?
Moonlake Immunotherapeutics share touched a 52 week high of $62.75 on and a 52 week low of $5.95 on . Moonlake Immunotherapeutics stock price today i.e. is closed at $9.16,which is 85.40% down from its 52 week high and 53.95% up from its 52 week low.
What is Moonlake Immunotherapeutics's market capitalisation today?
Moonlake Immunotherapeutics market capitalisation is $0.00T as on .
How to invest in Moonlake Immunotherapeutics Stock (MLTX) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Moonlake Immunotherapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Moonlake Immunotherapeutics Shares that will get you 0.1638 shares as per Moonlake Immunotherapeutics share price of $9.16 per share as on October 22, 2025 at 1:29 am IST.
What is the minimum amount required to buy Moonlake Immunotherapeutics Stock (MLTX) from India?
Indian investors can start investing in Moonlake Immunotherapeutics (MLTX) shares with as little as ₹87.965 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹879.65 in Moonlake Immunotherapeutics stock (as per the Rupee-Dollar exchange rate as on ).
Based on Moonlake Immunotherapeutics share’s latest price of $9.16 as on October 22, 2025 at 1:29 am IST, you will get 1.0917 shares of Moonlake Immunotherapeutics. Learn more about
fractional shares .